Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 5Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Waldenstrom Macroglobulinemia 1Prostatic Neoplasms 1Neurotoxicity Syndromes 1Neuroblastoma 1Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Diseases 1Graft vs Host Disease 1Central Nervous System Neoplasms 1

Interventions

gallium Ga 68 dotatate 2etoposide phosphate 2Vincristine 2Thiotepa 2Temozolomide 2Mesna 2Magnetic Resonance Spectroscopy 2Etoposide 2Cyclophosphamide 2Carboplatin 23-Iodobenzylguanidine 2naxitamab 1fludarabine 1eliglustat 1Vaccines, DNA 1Topotecan 1Tamoxifen 1Rituximab 1Lenalidomide 1Isotretinoin 1Irinotecan 1Ifosfamide 1Hydrocortisone 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Ga(III)-DOTATOC 1Filgrastim 1Doxorubicin 1Cisplatin 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neuroblastoma × Rituximab × Clear all
NCT00790413 2021-02-21

Haploidentical Stem Cell Transplantation in Neuroblastoma

Lund University Hospital

Phase EARLY_PHASE1 Unknown
15 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡